Wolter P, Schöffski P. Targeted therapies in the treatment of GIST: Adverse events and maximising the benefits of sunitinib through proactive therapy management. AO [Internet]. 2010 Jan. 1 [cited 2025 Feb. 26];49(1):13-2. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/32321